PRAN News 1.95 04/21/2014 21:46:28 Prana Biotechnology Ltd (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prana Biotechnology Ltd (PRAN) 1.95 $PRAN

Prana Biotechnology Stock Hits New Low
ACCESSWIRE - Wed Apr 16, 9:47AM CDT
Prana Biotechnology (NASDAQRAN) share value has been tumbling over the last month, closing at $1.74 Apr. 15, down 15 cents from the previous day's close of $1.89.

The Worst Biotech Failures of the Week
Cory Renauer, The Motley Fool - Motley Fool - Tue Apr 08, 8:30AM CDT
Things were tough all over last week as the biotechnology industry continued its month-long slide. It was also a rough week in the clinic as an unusual number of companies announced disappointing clinical results and trial stoppages. Amgen ...

This Week in Biotech: Data Disappointments Come in Threes
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 05, 1:15PM CDT
With the  SPDR S&P Biotech Index  up  37% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...

3 Stocks Under $10 Making Big Moves
at The Street - Fri Apr 04, 7:43AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries
at The Street - Fri Apr 04, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
ACCESSWIRE - Wed Apr 02, 8:49AM CDT
On Apr. 1, MannKind Corp. (NASDAQ:MNKD) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to recommend that Afrezza, its inhalable insulin, be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes.

Why Prana Biotechnology (PRAN) Stock Is Down Today
at The Street - Tue Apr 01, 9:13AM CDT
Prana Biotechnology (PRAN) continued to decline on Tuesday after the company announced on Monday its phase II study of PBT2 in Alzheimer's disease failed. The experimental drug did not reach the study's main endpoint of a statistically significant...

Downgrade Alert for Prana Biotechnology (PRAN)
Comtex SmarTrend(R) - Tue Apr 01, 7:03AM CDT
Prana Biotechnology (NASDAQRAN) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $2.80 on volume of 23.6 million shares, above average daily volume of 2.9 million. In the past 52 weeks, shares of Prana Biotechnology have traded between a low of $2.12 and a high of $13.29 and closed yesterday at $2.80, which is 32% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.6%.

Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
ACCESSWIRE - Tue Apr 01, 12:59AM CDT
Bank of America Corporation (NYSE: BAC) - For an in-depth report on Bank of America Corporation follow: www.BullTrends.com/stockquote/BAC

Investor Beat: The End of the First Quarter -- How Did We Do?
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:50PM CDT
The first quarter of 2014 officially wrapped up today, and though the Dow, Nasdaq and S&P were all up today, the quarter itself was the worst since the end of 2012. Are stocks finally pulling back enough for investors to find value on the market...

Big Movers Today: Panera, Delta, GM, and Prana Biotechnology
Chris Hill, The Motley Fool - Motley Fool - Mon Mar 31, 6:34PM CDT
Shares of Panera Bread moved upward today, after the stock got an analyst upgrade from Wedbush. Delta Airlines stock is also on the rise, after announcing a partnership with Virgin Atlantic. Shares of General Motors fell today in advance of...

Down 70%: Is Prana Biotechnology Ltd. a Buy?
David Williamson, The Motley Fool - Motley Fool - Mon Mar 31, 6:03PM CDT
The biggest loser today in the biotech space was Prana Biotechnology , down a massive 70% because its candidate Alzheimer's drug PBT2 failed its phase 2 trial. The drug failed not only to improve cognitive function, but it also failed to affect...

Lions Gate and Prana are big market movers
By The Associated Press - AP - Mon Mar 31, 3:57PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Why Prana Biotechnology Limited Got Pummeled
Brian Pacampara, The Motley Fool - Motley Fool - Mon Mar 31, 1:22PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Prana Biotechnology Limited plummeted 70%...

Hot Stock: Prana Biotechnology, Shares Drop 70.4% (PRAN)
Comtex SmarTrend(R) - Mon Mar 31, 10:11AM CDT
Prana Biotechnology (NASDAQRAN) is one of today's worst performing low-priced stocks, down 70.4% to $2.92 on 5.3x average daily volume. Thus far today, Prana Biotechnology has traded 15.5 million shares, vs. average volume of 2.9 million shares per day. The stock has underperformed the Dow (-70.4% to the Dow's 0.7%) and underperformed the S&P 500 (-70.4% to the S&P's 0.8%) during today's trading.

Ahead of the Bell: Prana Biotechnology shares skid
By The Associated Press - AP - Mon Mar 31, 8:00AM CDT
Shares of Prana Biotechnology Ltd. shed most of their value Monday before markets opened and after the Australian drug developer said its most advanced potential treatment missed the main goal in a study of patients with Alzheimer's disease.

Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease
PR Newswire - Mon Mar 31, 6:05AM CDT
Prana Biotechnology (ASXBT/NASDAQRAN) has today released the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease ("IMAGINE" Trial), based on draft results.

Prana Alzheimer's Study Fails
at The Street - Mon Mar 31, 5:54AM CDT
The experimental drug PBT2 failed to reduce beta amyloid plaque in the brain and couldn't improve cognition or function in Alzheimer's patients.

Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health
PR Newswire - Fri Mar 28, 11:19AM CDT
On Thursday, March 27, 2014, the NASDAQ Composite ended at 4,151.23, down 0.54%, the Dow Jones Industrial Average edged 0.03% lower to 16,264.23, and the S&P 500 closed at 1,849.04, down 0.19%. The losses were broad based with seven out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 671.20, down 0.13%, and the index has fallen by 2.20% in last one month. Investor-Edge has initiated coverage on the following equities: Prana Biotechnology Ltd (NASDAQ: PRAN), Amarin Corp. PLC (NASDAQ: AMRN), United Therapeutics Corp. (NASDAQ: UTHR) and OPKO Health Inc. (NYSE: OPK). Free technical research on PRAN, AMRN, UTHR and OPK can be downloaded upon signing up at:

3 Biotechs Expecting Data
Brian Orelli, The Motley Fool - Motley Fool - Fri Mar 21, 3:09PM CDT
The release of clinical trial data can be make-or-break moments for biotech companies. Three companies, Exelixis , Vertex Pharmaceuticals , and Prana Biotechnology are finishing up trials, and should release data shortly. Exelixis' trials,...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 172

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 134

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 118

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Equifax Unveils AI Advisory Service for Lenders' Success

Updated Category News Views 308

Empowering Lenders with Equifax Ignite AI Advisor Equifax has recently launched a transformative tool known as the Equifax Ignite AI Advisor, which is set to revolutionize how lenders operate. This innovative product aims to provide lenders with precise, actionable insights that can significantly improve decision-making processes and account growth. By leveraging advanced...

Continue Reading
Daily Overview: Spain's Stocks Experience Positive Surge

Updated Category News Views 153

Spain's Stock Market Closes on a Positive Note On a recent trading day, stocks in Spain showcased an encouraging uptick, particularly noted after the closing bell rang on Friday. The uptrend was primarily driven by gains in various sectors, which included Consumer Goods, Chemical, Petroleum & Plastic, as well as Telecoms & IT. These sectors played a vital role in...

Continue Reading
AGCO Celebrates Tiina Herlevi's 2025 Women MAKE Award Win

Updated Category News Views 195

AGCO Celebrates Leadership in Manufacturing AGCO, an acknowledged leader in the world of agricultural machinery and precision ag technology, has proudly announced that Tiina Herlevi has been honored with the 2025 Women MAKE Award. This prestigious recognition comes as a testament to her unwavering commitment to excellence and innovation within the manufacturing sector....

Continue Reading
eGain Delivers Impressive Q1 2026 Performance and Guidance

Updated Category News Views 206

Introduction to eGain's Financial Journey With an unwavering commitment to enhancing customer experience (CX) through AI automation, eGain Corporation (NASDAQ: EGAN) continues to make significant strides. Recently, eGain reported its fiscal 2026 first quarter results, showcasing impressive growth metrics and an optimistic outlook for the upcoming quarters. Q1 2026...

Continue Reading
Optimize Your Vehicle with Expert Multi-Point Inspection Services

Updated Category News Views 159

Optimize Your Vehicle with Expert Multi-Point Inspection Services Local drivers can take advantage of a multi-point inspection service at Auction Direct USA, designed to ensure their vehicles remain in peak condition. The Importance of Regular Vehicle Inspections Maintaining your vehicle's health is essential for both safety and longevity. Regular multi-point inspections...

Continue Reading